Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Vivek P Chavda, Anjali Pandya, Erica Kypreos, Vandana Patravale & Vasso Apostolopoulos. (2022) Chlamydia trachomatis: quest for an eye-opening vaccine breakthrough. Expert Review of Vaccines 21:6, pages 771-781.
Read now
Read now
Articles from other publishers (3)
Sukumar Pal, Anatoli Slepenkin, Jiin Felgner, D. Huw Davies, Philip Felgner & Luis M. de la Maza. (2023) Evaluation of Four Adjuvant Combinations, IVAX-1, IVAX-2, CpG-1826+Montanide ISA 720 VG and CpG-1018+Montanide ISA 720 VG, for Safety and for Their Ability to Elicit Protective Immune Responses in Mice against a Respiratory Challenge with Chlamydia muridarum. Pathogens 12:7, pages 863.
Crossref
Crossref
Delia F. Tifrea, Wei He, Sukumar Pal, Angela C. Evans, Sean F. Gilmore, Nicholas O. Fischer, Amy Rasley, Matthew A. Coleman & Luis M. de la Maza. (2021) Induction of Protection in Mice against a Chlamydia muridarum Respiratory Challenge by a Vaccine Formulated with the Major Outer Membrane Protein in Nanolipoprotein Particles. Vaccines 9:7, pages 755.
Crossref
Crossref
Han Zhang, Xiang Li, Juan Wang, Qi Cheng, Yunxiao Shang & Guizhen Wang. (2021)
Baicalin relieves
Mycoplasma pneumoniae
infection‑induced lung injury through regulating microRNA‑221 to inhibit the TLR4/NF‑κB signaling pathway
. Molecular Medicine Reports 24:2.
Crossref
Crossref